CC
Neutral signalScored 2026-09-06 Drivers: fundamentals. Moteurs : fondamentaux.
Research, not advice.
À propos
The Chemours Company
- Nom
- The Chemours Company
- Secteur
- Basic Materials
- Industrie
- Chemicals - Specialty
- Bourse
- NYSE
- Capitalisation
- $1.9B
- Employés
- 5,700
- PDG
- Denise Dignam
- Site web
- https://www.chemours.com
- Marché
- APDASHAXTACBTECVTESI
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
ACHAT TOTAL: 22 378 titres (~348 511,10 $ US)
- Insiders
- Dignam DeniseCowan AlisterCRANSTON MARY B
- Total bought
-
$348,511
Avg buy (VWAP, 90d window) $15.49 vs last close —
- Total sold
-
—
Avg sell (VWAP, 90d window) —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-11
- Last synced
-
2026-08-21 23:36:53
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-12 | Familiar Calderon Gerardo | Buy · P | 1,935 | $15.53 | $30,051 | Form 4 |
| 2026-08-11 | Dignam Denise | Buy · P | 3,378 | $14.95 | $50,501 | Form 4 |
| 2026-08-07 | CRANSTON MARY B | Buy · P | 6,000 | $15.82 | $94,950 | Form 4 |
| 2026-08-07 | Cowan Alister | Buy · P | 13,000 | $15.62 | $203,060 | Form 4 |
| 2026-08-07 | Foley Michael Robert | Buy · P | 1,934 | $15.51 | $30,000 | Form 4 |
| 2026-08-07 | Martinko Joseph T. | Buy · P | 1,940 | $15.47 | $30,009 | Form 4 |
| 2026-08-06 | HOSTETTER SHANE | Buy · P | 3,350 | $14.94 | $50,049 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2024-01-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-08-09 | Michael C. Burgess | Purchase | $15,001 - $50,000 |
| 2023-07-06 | Michael C. Burgess | Sale (Partial) | $1,001 - $15,000 |
| 2023-07-06 | Michael C. Burgess | Purchase | $15,001 - $50,000 |
| 2022-11-03 | Ro Khanna | Purchase | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-09-06 Drivers: fundamentals. Moteurs : fondamentaux.
CC presents a deeply distressed financial profile with near-insolvent leverage (D/E of 18.34), negative interest coverage, and deteriorating cash flows that overwhelm any catalytic signal.
The first sentence of the analysis written for CC on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Unavailable or mixed. Current ratio 1.78 · operating margin -0.1% — readings disagree
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 15.5% | 19.9% | 21.5% | 23.7% | 21.8% | |
| Ebit Margin | -0.1% | 6.8% | -1.8% | 13.2% | 13.6% | |
| Ebitda Margin | 5.7% | 12.0% | 3.2% | 17.5% | 18.6% | |
| Operating Profit Margin | -0.1% | 7.7% | -2.0% | 11.5% | 10.6% | |
| Pretax Profit Margin | -4.8% | 2.2% | -5.2% | 10.8% | 10.7% | |
| Continuous Operations Profit Margin | -6.6% | 1.5% | -3.9% | 8.5% | 9.6% | |
| Net Profit Margin | -6.6% | 1.5% | -3.9% | 8.5% | 9.6% | |
| Bottom Line Profit Margin | -6.6% | 1.5% | -3.9% | 8.5% | 9.6% | |
| Current Ratio | 1.780 | 1.678 | 1.543 | 1.700 | 1.800 | |
| Quick Ratio | 0.849 | 0.862 | 0.999 | 0.957 | 1.209 | |
| Solvency Ratio | -0.006 | 0.056 | 0.009 | 0.133 | 0.143 | |
| Cash Ratio | 0.399 | 0.395 | 0.484 | 0.583 | 0.781 | |
| Price To Earnings Ratio | -4.588 | 29.138 | -19.712 | 8.231 | 9.095 | |
| Price To Earnings Growth Ratio | 0.008 | -0.214 | 0.138 | 10.124 | 0.051 | |
| Forward Price To Earnings Growth Ratio | 0.008 | -0.214 | 0.138 | 10.124 | 0.051 | |
| Price To Earnings Diluted Ratio | -4.605 | 29.649 | -19.712 | 8.389 | 9.322 | |
| Price To Earnings Diluted Growth Ratio | 0.008 | -0.219 | 0.137 | 6.040 | 0.054 | |
| Price To Book Ratio | 7.091 | 4.183 | 6.373 | 4.297 | 5.121 | |
| Price To Sales Ratio | 0.305 | 0.437 | 0.773 | 0.696 | 0.872 | |
| Price To Free Cash Flow Ratio | 34.758 | -2.544 | 25.251 | 10.619 | 10.308 | |
| Price To Operating Cash Flow Ratio | 6.715 | -3.991 | 8.447 | 6.301 | 6.800 | |
| Debt To Assets Ratio | 0.621 | 0.580 | 0.521 | 0.508 | 0.528 | |
| Debt To Equity Ratio | 18.340 | 7.210 | 5.833 | 3.505 | 3.688 | |
| Debt To Capital Ratio | 0.948 | 0.878 | 0.854 | 0.778 | 0.787 | |
| Long Term Debt To Capital Ratio | 0.945 | 0.869 | 0.842 | 0.764 | 0.775 | |
| Financial Leverage Ratio | 29.528 | 12.442 | 11.195 | 6.902 | 6.984 | |
| Working Capital Turnover Ratio | 4.577 | 4.496 | 4.549 | 4.862 | 4.739 | |
| Operating Cash Flow Ratio | 0.157 | -0.351 | 0.224 | 0.399 | 0.438 | |
| Operating Cash Flow Sales Ratio | 0.045 | -0.109 | 0.091 | 0.111 | 0.128 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.193 | 1.569 | 0.335 | 0.593 | 0.660 | |
| Debt Service Coverage Ratio | 0.598 | 2.047 | 1.073 | 5.010 | 5.286 | |
| Interest Coverage Ratio | -0.019 | 1.678 | -0.591 | 4.822 | 3.643 | |
| Short Term Operating Cash Flow Coverage Ratio | 2.538 | -11.722 | 10.902 | 17.558 | 32.560 | |
| Operating Cash Flow Coverage Ratio | 0.058 | -0.145 | 0.129 | 0.195 | 0.204 | |
| Capital Expenditure Coverage Ratio | 1.239 | -1.758 | 1.503 | 2.459 | 2.939 | |
| Dividend Paid And Capex Coverage Ratio | 0.907 | -1.246 | 1.071 | 1.638 | 1.846 | |
| Dividend Payout Ratio | -0.202 | 1.721 | -0.626 | 0.266 | 0.270 | |
| Enterprise Value Multiple | 17.125 | 8.914 | 39.557 | 6.306 | 6.852 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 15.5% | ▼-4.4% | ▼-4.9% |
| Ebit Margin | -0.1% | ▼-6.9% | ▼-6.5% |
| Ebitda Margin | 5.7% | ▼-6.2% | ▼-5.7% |
| Operating Profit Margin | -0.1% | ▼-7.8% | ▼-5.6% |
| Pretax Profit Margin | -4.8% | ▼-7.0% | ▼-7.5% |
| Continuous Operations Profit Margin | -6.7% | ▼-8.1% | ▼-8.4% |
| Net Profit Margin | -6.7% | ▼-8.1% | ▼-8.4% |
| Bottom Line Profit Margin | -6.7% | ▼-8.1% | ▼-8.4% |
| Current Ratio | 1.780 | ▲0.102 | ▲0.080 |
| Quick Ratio | 0.849 | ▼-0.013 | ▼-0.126 |
| Solvency Ratio | -0.006 | ▼-0.062 | ▼-0.073 |
| Cash Ratio | 0.399 | ▲0.003 | ▼-0.130 |
| Price To Earnings Ratio | -4.588 | ▼-33.725 | ▼-9.020 |
| Price To Earnings Growth Ratio | 0.008 | ▲0.222 | ▼-2.013 |
| Forward Price To Earnings Growth Ratio | 0.008 | ▲0.222 | ▼-2.013 |
| Price To Earnings Diluted Ratio | -4.606 | ▼-34.255 | ▼-9.214 |
| Price To Earnings Diluted Growth Ratio | 0.008 | ▲0.227 | ▼-1.196 |
| Price To Book Ratio | 7.091 | ▲2.908 | ▲1.678 |
| Price To Sales Ratio | 0.305 | ▼-0.132 | ▼-0.311 |
| Price To Free Cash Flow Ratio | 34.758 | ▲37.302 | ▲19.079 |
| Price To Operating Cash Flow Ratio | 6.715 | ▲10.706 | ▲1.860 |
| Debt To Assets Ratio | 0.621 | ▲0.042 | ▲0.070 |
| Debt To Equity Ratio | 18.340 | ▲11.130 | ▲10.625 |
| Debt To Capital Ratio | 0.948 | ▲0.070 | ▲0.099 |
| Long Term Debt To Capital Ratio | 0.945 | ▲0.075 | ▲0.105 |
| Financial Leverage Ratio | 29.528 | ▲17.086 | ▲16.118 |
| Working Capital Turnover Ratio | 4.577 | ▲0.081 | ▼-0.068 |
| Operating Cash Flow Ratio | 0.157 | ▲0.508 | ▼-0.017 |
| Operating Cash Flow Sales Ratio | 0.045 | ▲0.155 | ▼-0.008 |
| Free Cash Flow Operating Cash Flow Ratio | 0.193 | ▼-1.375 | ▼-0.477 |
| Debt Service Coverage Ratio | 0.598 | ▼-1.449 | ▼-2.205 |
| Interest Coverage Ratio | -0.019 | ▼-1.697 | ▼-1.925 |
| Short Term Operating Cash Flow Coverage Ratio | 2.538 | ▲14.261 | ▼-7.829 |
| Operating Cash Flow Coverage Ratio | 0.058 | ▲0.203 | ▼-0.030 |
| Capital Expenditure Coverage Ratio | 1.239 | ▲2.998 | ▼-0.037 |
| Dividend Paid And Capex Coverage Ratio | 0.907 | ▲2.153 | ▲0.064 |
| Dividend Payout Ratio | -0.202 | ▼-1.923 | ▼-0.488 |
| Enterprise Value Multiple | 17.125 | ▲8.211 | ▲1.375 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $1.77B | $2.53B | $4.70B | $4.76B | $5.54B | |
| Enterprise value | $5.69B | $6.17B | $7.79B | $7.54B | $8.07B | |
| EV / Sales | 0.98x | 1.07x | 1.28x | 1.10x | 1.27x | |
| EV / Op. cash flow | 21.54x | -9.74x | 14.02x | 9.98x | 9.92x | |
| EV / Free cash flow | 111.48x | -6.21x | 41.90x | 16.82x | 15.03x | |
| EV / EBITDA | 17.12x | 8.91x | 39.56x | 6.31x | 6.85x | |
| Net debt / EBITDA | 11.79x | 5.26x | 15.72x | 2.33x | 2.15x | |
| Current ratio | 1.78x | 1.68x | 1.54x | 1.70x | 1.80x | |
| Income quality | -0.68x | -7.36x | -2.34x | 1.31x | 1.34x | |
| Graham number | — | $7 | — | $24 | $23 | |
| Graham net-net | -$34 | -$33 | -$35 | -$27 | -$24 | |
| Tax burden | 139.4% | 67.7% | 74.8% | 78.0% | 89.9% | |
| Interest burden | 3462.5% | 32.5% | 289.1% | 82.0% | 78.5% | |
| Working capital | $1.31B | $1.22B | $1.35B | $1.32B | $1.49B | |
| Invested capital | $4.71B | $4.71B | $4.93B | $4.85B | $4.98B | |
| Return on assets | -5.2% | 1.1% | -2.9% | 7.6% | 8.1% | |
| Operating ROA | -0.1% | 5.6% | -1.5% | 10.3% | 9.2% | |
| Return on tangible assets | -5.3% | 1.2% | -2.9% | 7.7% | 8.2% | |
| Return on equity | -154.4% | 14.2% | -32.3% | 52.2% | 56.2% | |
| Return on invested capital | -0.1% | 5.2% | -1.6% | 10.5% | 10.5% | |
| Return on capital employed | -0.1% | 7.8% | -2.1% | 13.7% | 11.8% | |
| Earnings yield | -21.8% | 3.4% | -5.1% | 12.2% | 11.0% | |
| Free cash flow yield | 2.9% | -39.3% | 4.0% | 9.4% | 9.7% | |
| Capex / Op. cash flow | 80.7% | -56.9% | 66.5% | 40.7% | 34.0% | |
| Capex / Depreciation | 62.6% | 119.6% | 120.5% | 105.5% | 87.4% | |
| Capex / Sales | 3.7% | 6.2% | 6.1% | 4.5% | 4.4% | |
| SG&A / Sales | 13.8% | 10.1% | 21.2% | 10.4% | 9.3% | |
| R&D / Sales | 1.9% | 1.9% | 1.8% | 1.7% | 1.7% | |
| Stock comp / Sales | 0.4% | 0.3% | 0.3% | 0.4% | 0.5% | |
| Intangibles / Total assets | 0.7% | 0.7% | 1.3% | 1.5% | 1.4% | |
| Days sales outstanding | 43d | 49d | 37d | 33d | 41d | |
| Days payables outstanding | 69d | 88d | 87d | 85d | 84d | |
| Operating cycle | 159d | 165d | 140d | 132d | 122d | |
| Cash conversion cycle | 90d | 76d | 53d | 47d | 38d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-14 Chemours Expands Low-GWP Refrigerant Portfolio for Data Centers CC expands its low-GWP Opteon refrigerant portfolio to meet rising cooling needs from AI-driven data centers and support decarbonization goals.
- 2026-08-13 Birkenstock (BIRK) Reports Strong Q3 Growth Amid Market Challenges Birkenstock (BIRK) shares surged following the release of its Q3 results for June, showing a 13% year-over-year revenue increase to â¬719.5 million. Although t
- 2026-08-13 Securities Fraud Investigation Into The Chemours Company (CC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) investors concerning the Company''s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CHEMOURS COMPANY (CC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On Augus.
- 2026-08-13 Securities Fraud Investigation Into The Chemours Company (CC) Announced -- Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm [url="]Glancy Prongay Wolke and Rotter LLP[/url], a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf
- 2026-08-13 The Chemours Company (CC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) investors concerning the Company''s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN THE CHEMOURS COMPANY (CC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by emai.
- 2026-08-11 Chemours'' Q2 Earnings & Revenues Lag Estimates on Lower Volumes CC''s Q2 loss narrows, but lower volumes and sales weigh on results as it outlines a cautious Q3 outlook.
- 2026-08-10 Chemours Launches Opteon™ ZE and Opteon™ 515B Refrigerants for Chiller Applications Powering Data Centers, Commercial Buildings, and Other Mission Critical Environments New additions to the Opteon™ portfolio support high-performance, sustainable cooling solutions in stationary chillers for AI-driven data centers, and commercial HVAC applications WILMINGTON, Del., Aug. 10, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced the launch of Opteon™ ZE (R-1234ze(E)) and Opteon™ 515B (R-515B) for stationary chiller applications.
- 2026-08-07 Leading Women-Run Companies Shaping the Future of Business CNC, DAR, GD, FCEL and CC stocks show how women-led companies are redefining growth with discipline, agility and results.
- 2026-08-06 Chemours: Close To A ''Perfect'' Rotation, With A ''Buy'' In Q2 2026 (Rating Upgrade) Chemours is upgraded to ''BUY'' with a $20 PT and $30 fair value, reflecting renewed upside after recent volatility. CC''s recent rally was driven by sentiment, not fundamentals, but the company now shows improving liquidity, debt reduction, and solid EBITDA guidance. Risks remain from regulatory liabilities and elevated leverage, but CC''s divestment plan and Opteon growth support a high-conviction turnaround thesis.
- 2026-08-06 The Chemours Company (CC) Q2 2026 Earnings Call Transcript The Chemours Company (CC) Q2 2026 Earnings Call Transcript